Pharmacokinetics and Bioequivalence of XC8 10 mg and 40 mg Tablets in Fasted Volunteers

NCT05558462 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza
Respiratory Viral Infection

Interventions

DRUG: XC8

Sponsor

Valenta Pharm JSC